Ensysce Biosciences, Inc. ENSC
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$0.42$0.47
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -48.30% | -82.79% | 22.35% | -663.48% | 11.90% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 157.88% | -78.70% | 824.90% | 433.51% | 1,138.42% |
| Change in Net Operating Assets | 96.20% | -79.70% | -71.18% | 203.74% | -215.37% |
| Cash from Operations | 27.50% | -105.04% | -99.69% | -82.91% | -17.19% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -35.38% | -9.03% | 43.98% | 52.93% |
| Issuance of Common Stock | -- | -- | 91.23% | -10.37% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -105.75% | -- | -162.68% | -100.21% | -- |
| Cash from Financing | 1.48% | -105.08% | 3,597.16% | -64.86% | 3,744.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.82% | -692.90% | 504.77% | -117.31% | 64.39% |